Search for other papers by Rudolf Hoermann in
Google Scholar
PubMed
Search for other papers by John E.M. Midgley in
Google Scholar
PubMed
Search for other papers by Rolf Larisch in
Google Scholar
PubMed
Ruhr Center for Rare Diseases (CeSER), Ruhr University of Bochum and Witten/Herdecke University, Bochum, Germany
Search for other papers by Johannes W. Dietrich in
Google Scholar
PubMed
3 ) and FT 4 , which also maintain interdependent equilibrium positions. While allowing for greater flexibility in the physiological responses of individuals across the euthyroid reference range, this may demand significant variation in the
Search for other papers by Shinsuke Shinkai in
Google Scholar
PubMed
Medical Education Center, Hamamatsu University School of Medicine, Shizuoka, Japan
Search for other papers by Kenji Ohba in
Google Scholar
PubMed
Search for other papers by Kennichi Kakudo in
Google Scholar
PubMed
Search for other papers by Takayuki Iwaki in
Google Scholar
PubMed
Search for other papers by Yoshihiro Mimura in
Google Scholar
PubMed
Search for other papers by Akio Matsushita in
Google Scholar
PubMed
Search for other papers by Go Kuroda in
Google Scholar
PubMed
Search for other papers by Yuki Sakai in
Google Scholar
PubMed
Search for other papers by Nobuhiko Nishino in
Google Scholar
PubMed
Department of Pharmacology, Hamamatsu University School of Medicine, Shizuoka, Japan
Search for other papers by Kazuo Umemura in
Google Scholar
PubMed
Search for other papers by Takafumi Suda in
Google Scholar
PubMed
Search for other papers by Shigekazu Sasaki in
Google Scholar
PubMed
of 0.01 mIU/L (reference range: 0.05–5.00), a free thyroxine level of 23.2 pmol/L (reference range: 11.6–21.9), and a free tri-iodothyronine level of 6.6 pmol/L (reference range: 3.5–6.2) as measured by ECLusys (Roche Diagnostics K.K., Tokyo, Japan
Search for other papers by Tina Toft Kristensen in
Google Scholar
PubMed
Search for other papers by Jacob Larsen in
Google Scholar
PubMed
Search for other papers by Palle Lyngsie Pedersen in
Google Scholar
PubMed
Search for other papers by Anne-Dorthe Feldthusen in
Google Scholar
PubMed
Search for other papers by Christina Ellervik in
Google Scholar
PubMed
Search for other papers by Søren Jelstrup in
Google Scholar
PubMed
Search for other papers by Jan Kvetny in
Google Scholar
PubMed
Introduction Whereas hemithyroidectomy is associated with a recognized risk of overt hypothyroidism [ 1 ], the significance of perturbations of thyroid-stimulating hormone (TSH) and thyroid hormones within the laboratory reference ranges after
Search for other papers by Cléber P. Camacho in
Google Scholar
PubMed
Search for other papers by Susan C. Lindsey in
Google Scholar
PubMed
Search for other papers by Teresa S. Kasamatsu in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Alberto L. Machado in
Google Scholar
PubMed
Search for other papers by João Roberto M. Martins in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Rosa Paula M. Biscolla in
Google Scholar
PubMed
Search for other papers by Magnus R. Dias da Silva in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by José Gilberto H. Vieira in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Rui M.B. Maciel in
Google Scholar
PubMed
diagnosis of nodular thyroid disease (NTD) while other guidelines assume a neutral or a contrary position regarding the use of sCT for NTD due to false-positive results, cost-effectiveness, and large reference range of assays [ 2 , 3 , 4 , 5 , 6 , 7 , 8
Department of Endocrinology, Universidade Federal do Rio de Janeiro – UFRJ, Faculdade de Medicina, Rio de Janeiro, RJ, Brazil
Search for other papers by Marise Codeco de Andrade Barreto in
Google Scholar
PubMed
Search for other papers by Natalia Treistman in
Google Scholar
PubMed
Search for other papers by Lara Bessa Campelo Pinheiro Cavalcante in
Google Scholar
PubMed
Search for other papers by Daniel Bulzico in
Google Scholar
PubMed
Search for other papers by Fernanda Accioly de Andrade in
Google Scholar
PubMed
Search for other papers by Rossana Corbo in
Google Scholar
PubMed
Department of Endocrinology, Universidade Federal do Rio de Janeiro – UFRJ, Faculdade de Medicina, Rio de Janeiro, RJ, Brazil
Search for other papers by Paulo Alonso Garcia Alves Junior in
Google Scholar
PubMed
Department of Endocrinology, Universidade Federal do Rio de Janeiro – UFRJ, Faculdade de Medicina, Rio de Janeiro, RJ, Brazil
Search for other papers by Fernanda Vaisman in
Google Scholar
PubMed
.01–7.81) AMH out-of-reference range for age 10 (21) N/A Age at AMH measurement 47 (100) 26.1 ± 9.2 25 (12.4–50.8) Interval (years) between last RAI and AMH measurement 47 (100) 10.7 ± 7.2 10.5 (0.7–26.2) Pregnancies ( n = 17
Institute for Community Medicine, Greifswald, Germany
Search for other papers by Tilman Witte in
Google Scholar
PubMed
Search for other papers by Henry Völzke in
Google Scholar
PubMed
Search for other papers by Markus M. Lerch in
Google Scholar
PubMed
Search for other papers by Katrin Hegenscheid in
Google Scholar
PubMed
Search for other papers by Nele Friedrich in
Google Scholar
PubMed
Search for other papers by Till Ittermann in
Google Scholar
PubMed
Department of Medicine, Geisel School of Medicine at Dartmouth, Hanover, N.H., USA
Search for other papers by John A. Batsis in
Google Scholar
PubMed
Introduction Both thyroid disease and obesity are common disorders in the general population. Several studies have found a prevalence dependent on selected reference ranges from 0.1 to 2% for hypothyroidism [elevated thyroid
Departments of Vascular Medicine, University of Amsterdam, Amsterdam
Search for other papers by Laura P.B. Elbers in
Google Scholar
PubMed
Search for other papers by Hjalmar A. Boon in
Google Scholar
PubMed
Search for other papers by Maaike I. Moes in
Google Scholar
PubMed
Departments of Vascular Medicine, University of Amsterdam, Amsterdam
Search for other papers by Bregje van Zaane in
Google Scholar
PubMed
Departments of Vascular Medicine, University of Amsterdam, Amsterdam
Search for other papers by Dees P.M. Brandjes in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
Search for other papers by Harry R. Büller in
Google Scholar
PubMed
Einthoven Laboratory for Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Suzanne Cannegieter in
Google Scholar
PubMed
Departments of Vascular Medicine, University of Amsterdam, Amsterdam
Search for other papers by Victor E.A. Gerdes in
Google Scholar
PubMed
reference range had an increased risk of major bleeding compared to those with higher FT 4 levels, suggesting that FT 4 levels play a role in the etiology of major bleeding in VKA users. Bleeding is one of the major short-term complications after
Search for other papers by Marta Kostecka-Matyja in
Google Scholar
PubMed
Search for other papers by Anna Fedorowicz in
Google Scholar
PubMed
Search for other papers by Ewa Bar-Andziak in
Google Scholar
PubMed
Search for other papers by Tomasz Bednarczuk in
Google Scholar
PubMed
Search for other papers by Monika Buziak-Bereza in
Google Scholar
PubMed
Search for other papers by Paulina Dumnicka in
Google Scholar
PubMed
Search for other papers by Maria Górska in
Google Scholar
PubMed
Search for other papers by Małgorzata Krasnodębska in
Google Scholar
PubMed
Search for other papers by Beata Niedźwiedzka in
Google Scholar
PubMed
Search for other papers by Dorota Pach in
Google Scholar
PubMed
Search for other papers by Marek Ruchała in
Google Scholar
PubMed
Search for other papers by Katarzyna Siewko in
Google Scholar
PubMed
Search for other papers by Bogdan Solnica in
Google Scholar
PubMed
Search for other papers by Jerzy Sowiński in
Google Scholar
PubMed
Search for other papers by Małgorzata Szelachowska in
Google Scholar
PubMed
Search for other papers by Małgorzata Trofimiuk-Müldner in
Google Scholar
PubMed
Search for other papers by Katarzyna Wachowiak-Ochmańska in
Google Scholar
PubMed
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
determine reference intervals for thyroid hormones by local laboratories [ 13 ]. The reference ranges established for the general population are not relevant for pregnant women. Also, since the rapid hormonal changes during pregnancy must be addressed, there
Institut National de la Recherche Médicale, UMR U895, Université Nice-Sophia Antipolis, Nice, France
Search for other papers by Françoise Brucker-Davis in
Google Scholar
PubMed
Search for other papers by Patricia Panaïa-Ferrari in
Google Scholar
PubMed
Search for other papers by Jocelyn Gal in
Google Scholar
PubMed
Institut National de la Recherche Médicale, UMR U895, Université Nice-Sophia Antipolis, Nice, France
Search for other papers by Patrick Fénichel in
Google Scholar
PubMed
Search for other papers by Sylvie Hiéronimus in
Google Scholar
PubMed
5th or 10th percentile of the reference range for FT4 associated with normal TSH [ 3 , 4 ]. There is, however, the question of threshold for normal values, linked in part to the lack of laboratory reference ranges in pregnancy. The association of
Search for other papers by Selwan Khamisi in
Google Scholar
PubMed
Search for other papers by Peter Lindgren in
Google Scholar
PubMed
Search for other papers by F. Anders Karlsson in
Google Scholar
PubMed
University Hospital. Reference ranges for amniotic TSH (0.04-0.51 mU/l) and fT 4 (1.29-9.93 pmol/l) are based on the study by Baumann and Gronowski 2007 [ 12 ]. The ultrasound equipment used was Voluson E8, Expert (General Electric Co./GE Healthcare